Company: SMNR
Filing Date: 2025-10-21
Form Type: S-1
Source: 0001193125-25-245178
Chunk: 272

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-10-21
Form: S-1
Chunk 272
---
 subject to continued service through each vesting date. Additionally, Semnur will reimburse each outside director for reasonable travel expenses related to such director’s attendance at meetings of the Board and any committees thereof. All compensation of our non-employee directors is subject to approval by the Board and the foregoing expected compensation is subject to change pending such approval.Semnur’s employee directors will not receive additional compensation for their service as a director.176
DIRECTORS AND EXECUTIVE OFFICERS The following sets forth certain information, as of the date of this prospectus concerning the persons who are expected to serve as directors and executive officers of Semnur following the consummation of the Business Combination. Executive Officers and Directors The following table sets forth the name, age and position of each of the directors and executive officers of Semnur as of September 30, 2025.

| Name                              |     | Age |     | Position(s)                                                  |
| Executive Officers:               |     |     |     |                                                              |
| Jaisim Shah(4)                    |     |  65 |     | Chief Executive Officer, President and Director              |
| Henry Ji, Ph.D.(4)                |     |  61 |     | Executive Chairperson and Director                           |
| Stephen Ma                        |     |  53 |     | Chief Financial Officer, Senior Vice President and Secretary |
| Non-employee Directors:           |     |     |     |                                                              |
| Jay Chun, M.D., Ph.D.(1)(2)(3)(4) |     |  61 |     | Director                                                     |
| Dorman Followwill(1)(2)(3)        |     |  62 |     | Director                                                     |
| Annu Navani                       |     |  55 |     | Director                                                     |
| Yue Alexander Wu, Ph.D.(1)(2)(3)  |     |  62 |     | Director                                                     |

| (1) | Member of the Audit Committee. |

| (2) | Member of the Compensation Committee. |

| (3) | Member of the Semnur Nominating and Corporate Governance Committee. |

| (4) | Commercialization and Transaction Committee |

**Executive Officers Jaisim Shah.Mr. Shah serves as Semnur’s Chief Executive Officer and President and a member of the Board. He has served as Semnur’s President, Chief Executive Officer and a board member since its inception in 2013. Mr. Shah has more than